Mark Zuckerberg and Priscilla Chan are shifting their philanthropy towards using AI to accelerate biological research and aim to cure all diseases, unifying efforts under Biohub and integrating AI-focused labs to foster rapid scientific advancements.
The Chan Zuckerberg Initiative (CZI) has launched the Chan Zuckerberg Biohub New York (CZ Biohub NY), a biomedical research hub in New York City that aims to develop technologies to characterize and bioengineer immune cells. The goal is to create disease-specific "cellular endoscopes" that can detect early stages of disease in cells, monitor cell changes, and resolve diseases before they become untreatable. The CZ Biohub NY will collaborate with Columbia University, The Rockefeller University, and Yale University. The initiative is part of the larger CZ Biohub Network, which focuses on quantifying human biology to increase understanding of health and disease. The State of New York and New York City are contributing $10 million each to the CZ Biohub NY.
Mark Zuckerberg and Priscilla Chan, founders of the Chan Zuckerberg Initiative (CZI), announced plans to invest $250 million over 10 years to establish a new "biohub" in New York City focused on building cellular machines that can detect and treat diseases. The biohub will bring together researchers from Yale, Columbia, and Rockefeller to decode how immune cells sense and eliminate diseases like cancer and Alzheimer's. The long-term goal is to engineer cells that can detect and treat diseases before symptoms appear. The initiative is part of CZI's mission to cure, prevent, or manage all diseases by 2100.